LeMaitre Vascular, Inc.
LMAT
$92.34
-$4.25-4.40%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.27% | 13.53% | 13.07% | 14.11% | 13.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.27% | 13.53% | 13.07% | 14.11% | 13.19% |
| Cost of Revenue | 4.06% | 6.96% | 7.67% | 9.14% | 5.29% |
| Gross Profit | 17.45% | 16.53% | 15.57% | 16.48% | 17.18% |
| SG&A Expenses | 15.12% | 18.43% | 21.36% | 20.70% | 16.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.53% | 11.27% | 12.43% | 12.43% | 8.96% |
| Operating Income | 28.77% | 20.77% | 15.17% | 20.00% | 29.63% |
| Income Before Tax | 38.23% | 32.19% | 27.21% | 23.14% | 31.78% |
| Income Tax Expenses | 38.43% | 35.94% | 21.18% | 17.05% | 27.70% |
| Earnings from Continuing Operations | 38.17% | 31.10% | 29.08% | 25.04% | 33.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.17% | 31.10% | 29.08% | 25.04% | 33.02% |
| EBIT | 28.77% | 20.77% | 15.17% | 20.00% | 29.63% |
| EBITDA | 25.43% | 18.86% | 13.71% | 17.32% | 24.48% |
| EPS Basic | 36.98% | 30.00% | 27.97% | 23.97% | 31.73% |
| Normalized Basic EPS | 29.77% | 23.64% | 17.36% | 22.09% | 29.98% |
| EPS Diluted | 37.63% | 30.12% | 27.13% | 23.56% | 31.41% |
| Normalized Diluted EPS | 28.41% | 21.94% | 15.13% | 21.47% | 29.26% |
| Average Basic Shares Outstanding | 0.86% | 0.83% | 0.86% | 0.90% | 1.00% |
| Average Diluted Shares Outstanding | 2.10% | 2.33% | 2.75% | 1.43% | 1.56% |
| Dividend Per Share | 25.00% | 25.00% | 22.58% | 20.00% | 17.24% |
| Payout Ratio | -0.09% | -0.04% | -0.04% | -0.03% | -0.11% |